PERITONEAL ABSORPTION OF MOXALACTAM

被引：5

作者：

STEPHENS, NM

KRONFOL, NO

KLINE, BJ

POLK, RE

机构：

[1] MED COLL VIRGINIA HOSP & CLIN,SCH PHARM,RICHMOND,VA 23298

[2] MED COLL VIRGINIA HOSP & CLIN,DEPT NEPHROL,RICHMOND,VA 23298

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1983年 / 24卷 / 01期

关键词：

D O I：

10.1128/AAC.24.1.39

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：39 / 41

页数：3

共 5 条

[1]

BULGER RJ, 1965, JAMA-J AM MED ASSOC, V194, P140

[2] MEASUREMENT OF SERUM AND TISSUE CONCENTRATION OF MOXALACTAM USING HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].

DIVEN, WF ;

OBERMEYER, BD ;

WOLEN, RL ;

YU, VL ;

LYON, J ;

ZURAVLEFF, J .

THERAPEUTIC DRUG MONITORING, 1981, 3 (03) :291-295

[3] PHARMACOLOGY OF INTRA-PERITONEAL CEFAZOLIN IN PATIENTS UNDERGOING PERITONEAL-DIALYSIS [J].

KAYE, D ;

WENGER, N ;

AGARWAL, B .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :318-321

[4] CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS [J].

POPOVICH, RP ;

MONCRIEF, JW ;

NOLPH, KD ;

GHODS, AJ ;

TWARDOWSKI, ZJ ;

PYLE, WK .

ANNALS OF INTERNAL MEDICINE, 1978, 88 (04) :449-456

[5] COMPARISON OF CEFOTAXIME AND MOXALACTAM PHARMACOKINETICS AND TISSUE-LEVELS [J].

WISE, R ;

BAKER, S ;

LIVINGSTON, R .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (03) :369-371

← 1 →